Literature DB >> 21719594

Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.

Diane L Frankenfield1, Benjamin L Howell, Iris I Wei, Karyn K Anderson.   

Abstract

PURPOSE: Medication nonadherence due to cost issues among community-dwelling patients with end-stage renal disease (ESRD) enrolled in Medicare prescription drug plans was evaluated.
METHODS: Demographic and health status data were collected on 1329 patients with ESRD enrolled in Medicare Part D prescription drug plans who responded to a Centers for Medicare and Medicaid Services consumer survey in early 2007. The survey data were assessed for self-reported cost-related nonadherence (CRN), defined as delaying or not filling a prescription due to cost concerns. Multivariate logistic regression analysis was performed to evaluate CRN risk relative to patient demographic characteristics, socioeconomic status, other chronic conditions, health behaviors, and access to health care services.
RESULTS: Overall, survey respondents with ESRD were significantly more likely than those without ESRD to report CRN in the prior six months (unadjusted odds ratio [OR], 2.34; 95% confidence interval [CI], 2.00-2.75). After controlling for potential confounding factors such as other chronic conditions, the data analysis continued to show a significant association between ESRD and an increased risk of CRN (adjusted OR, 1.23; 95% CI, 1.07-1.41). Black race and receipt of Medicare Part D Low-Income Subsidy assistance were significant independent predictors of CRN for respondents with ESRD.
CONCLUSION: In early 2007, 31% of survey respondents with ESRD enrolled in Medicare Part D drug plans reported CRN in the preceding six months. After adjusting for potential confounders, respondents with ESRD remained 23% more likely than respondents without ESRD to report CRN in the preceding six months.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719594     DOI: 10.2146/ajhp100400

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  6 in total

1.  Sources of drug coverage among Medicare beneficiaries with ESRD.

Authors:  Benjamin L Howell; Christopher A Powers; Eric D Weinhandl; Wendy L St Peter; Diane L Frankenfield
Journal:  J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 10.121

2.  Cost-related medication non-adherence among U.S. adults with diabetes.

Authors:  Hyojung Kang; Jennifer Mason Lobo; Soyoun Kim; Min-Woong Sohn
Journal:  Diabetes Res Clin Pract       Date:  2018-06-23       Impact factor: 5.602

3.  Relationships of clinic size, geographic region, and race/ethnicity to the frequency of missed/shortened dialysis treatments.

Authors:  Chamberlain Obialo; Phillip G Zager; Orrin B Myers; William C Hunt
Journal:  J Nephrol       Date:  2014-01-21       Impact factor: 3.902

4.  Medicare part D research and policy highlights, 2012: impact and insights.

Authors:  Denys T Lau; JoAnn Stubbings
Journal:  Clin Ther       Date:  2012-03-13       Impact factor: 3.393

5.  Relationship of missed and shortened hemodialysis treatments to hospitalization and mortality: observations from a US dialysis network.

Authors:  Chamberlain I Obialo; William C Hunt; Khalid Bashir; Phillip G Zager
Journal:  Clin Kidney J       Date:  2012-08

Review 6.  How payment scheme affects patients' adherence to medications? A systematic review.

Authors:  Hamiza Aziz; Ernieda Hatah; Mohd Makmor Bakry; Farida Islahudin
Journal:  Patient Prefer Adherence       Date:  2016-05-13       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.